Compare KZIA & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZIA | PBHC |
|---|---|---|
| Founded | 1994 | 1859 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.2M | 80.2M |
| IPO Year | 2002 | 2014 |
| Metric | KZIA | PBHC |
|---|---|---|
| Price | $7.25 | $13.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 195.3K | 3.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | N/A | ★ 46.25 |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $12.06 |
| 52 Week High | $17.40 | $17.00 |
| Indicator | KZIA | PBHC |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 49.44 |
| Support Level | $5.74 | $13.43 |
| Resistance Level | $8.17 | $13.75 |
| Average True Range (ATR) | 1.19 | 0.13 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 34.08 | 77.33 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.